BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15259084)

  • 1. Determination of glycated hemoglobin in patients with advanced liver disease.
    Lahousen T; Hegenbarth K; Ille R; Lipp RW; Krause R; Little RR; Schnedl WJ
    World J Gastroenterol; 2004 Aug; 10(15):2284-6. PubMed ID: 15259084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4.
    Chen HS; Wu TE; Lin HD; Jap TS; Hsiao LC; Lee SH; Lin SH
    Am J Kidney Dis; 2010 May; 55(5):867-74. PubMed ID: 20202728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?
    Narbonne H; Renacco E; Pradel V; Portugal H; Vialettes B
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):598-603. PubMed ID: 11694860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of discordant HbA(1c): a method-dependent error.
    Dimeski G; Pretorius CJ; Russell AW; Miller SP; Bird RJ; Ungerer JP
    Med J Aust; 2009 Sep; 191(6):347-9. PubMed ID: 19769560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
    Gołembiewska E
    Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructosamine, glycated hemoglobin, and dietary carbohydrates.
    Misciagna G; Logroscino G; De Michele G; Cisternino AM; Guerra V; Freudenheim JL
    Clin Chim Acta; 2004 Feb; 340(1-2):139-47. PubMed ID: 14734205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients.
    Suzuki K; Yagi K; Oka R; Saiki Y; Kubota M; Sugihara M; Ito N; Kawashiri MA; Nohara A; Horita H; Takeda Y; Yamagishi M; Kobayashi J
    Clin Chem Lab Med; 2009; 47(1):70-4. PubMed ID: 19072031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nontraditional markers of glycemia: associations with microvascular conditions.
    Selvin E; Francis LM; Ballantyne CM; Hoogeveen RC; Coresh J; Brancati FL; Steffes MW
    Diabetes Care; 2011 Apr; 34(4):960-7. PubMed ID: 21335368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease.
    Bando Y; Kanehara H; Toya D; Tanaka N; Kasayama S; Koga M
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):368-72. PubMed ID: 19675058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficulties in interpreting HbA(1c) results.
    Homa K; Majkowska L
    Pol Arch Med Wewn; 2010 Apr; 120(4):148-54. PubMed ID: 20424541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of variant forms of haemoglobin according to the ratio of glycated haemoglobin to glycated albumin.
    Miyazaki A; Kohzuma T; Kasayama S; Koga M
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):441-4. PubMed ID: 22715294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases.
    Koga M; Kasayama S; Kanehara H; Bando Y
    Diabetes Res Clin Pract; 2008 Aug; 81(2):258-62. PubMed ID: 18513821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for consistency of the glycation gap in diabetes.
    Nayak AU; Holland MR; Macdonald DR; Nevill A; Singh BM
    Diabetes Care; 2011 Aug; 34(8):1712-6. PubMed ID: 21715524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemoglobin Glycosylation Index is not related with blood glucose.
    Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
    J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Level of glycation gap in a healthy subject.
    Dziedzic M; Petkowicz B; Michalak M; Solski J
    Ann Agric Environ Med; 2012; 19(4):842-5. PubMed ID: 23311817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country.
    Sharma TK; Parchwani H; Kaushik GG; Shankar V; Dahiya K; Ghalaut VS; Sharma N
    Clin Lab; 2011; 57(7-8):517-22. PubMed ID: 21888015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.